Companies / Canada
Generex Expands Oral Delivery Sales Network
October 2007 | Company News AlertAs US giant Pfizer winds up its inhaled insulin product Exubera on the back of disappointing sales, Canada's Generex is hoping to expand its own oral insulin spray, Generex Oral-lyn, into Africa. Generex, a biotech firm with a focus on oral drug delivery methods, has entered into an exclusive licensing deal with local firm Adcock Ingram for marketing, distribution and sale of the product in South
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
